Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung

Hong Yan1,2, Lei Bi2,3, Yunshan Wang2,4

  • 1Department of Laboratory Medicine, Nanjing Chest Hospital, 215 Guangzhou Road, Nanjing, 210029, China.

Scientific Reports
|March 25, 2017
PubMed

Insights

Researchers investigated 19 DDB1-CUL4 associated factors (DCAFs) in lung adenocarcinoma (LuADC). Elevated DTL levels correlate with poor survival and impact cell cycle and DNA repair, suggesting therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • DDB1-CUL4 associated factors (DCAFs) act as substrate receptors, but their roles in cancer, particularly lung adenocarcinoma (LuADC), are largely unknown.
  • CUL4A's oncogenic role is established, yet specific DCAFs contributing to cancer development require elucidation.

Purpose of the Study:

  • To investigate the potential impact of 19 defined DCAFs in human lung adenocarcinomas (LuADCs).
  • To identify specific DCAFs associated with LuADC development and patient survival.

Main Methods:

  • Integrative omics analyses were employed to assess DCAF expression in LuADCs.
  • Correlation analyses were performed between DCAF transcriptional levels, gene copy number variations, and patient overall survival.

Main Results:

  • mRNA levels of DTL, DCAF4, DCAF12, and DCAF13 were elevated, while VBRBP was reduced in LuADCs.
  • DTL's transcriptional level significantly and negatively correlated with overall survival, with DTL-correlated genes enriched in cell cycle and DNA repair pathways.
  • DTL overexpression was associated with decreased protein levels of tumor suppressors like PDCD4, NKX2-1, and PRKAA1.

Conclusions:

  • Different CUL4-DCAF axes play distinct roles in LuADC development.
  • DTL emerges as a potential therapeutic target in lung adenocarcinoma due to its association with survival and key cellular pathways.

Related Concept Videos